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BACKGROUND: Vascular calcification may be an important risk factor of cardiovascular disease in Chronic Kidney Disease (CKD). The pathobiology 
of vascular calcification in CKD is complex and involves 
some factors including inflammation, oxidative stress and 
balancing of calcification regulators. The aim of the study 
was to investigate the interaction between 8-isoprostane 
with calcification regulators such as matrix gla protein 
(MGP) and bone morphogenetic protein (BMP)-2 with 
vascular calcification in CKD.
METHODS: A cross-sectional study was performed on 63 
subjects undergoing haemodialysis maintenance for more 
than 3 months. Abdominal aortic calcification (AAC) was 
measured using a lateral abdominal X-ray for calcification 
in abdominal aorta, which is related to severity of calcific 
deposits at lumbar vertebral segment (L)1-L4. Serum levels 
of 8-isoprostane, MGP and BMP-2 were measured by 
enzyme-linked immunosorbent assay method. 
RESULTS: Results showed that 8-isoprostane levels 
were correlated with BMP-2 (r=0.266, p=0.018) and MGP 
levels (r=0.410, p=<0.001). MGP/BMP-2 levels ratio was 
correlated with AAC score (r=0.279, p=0.013). Subjects 
were then stratified into 3 groups based on AAC score: 0, 
1-6 and ≥7. The highest mean of MGP levels was in AAC 
score 1-6 group, and the highest mean of 8-isoprostane 
levels  was in AAC score ≥7. In the group of AAC score 
0, 8-isoprostane levels were correlated with MGP levels 
(r=0.499, p=0.001) and MGP/BMP-2 levels ratio (r=0.291, 
p=0.034). In AAC score 1-6 group, 8-isoprostane levels 
were correlated with BMP-2 (r=0.661, p=0.005) and MGP 
levels (r=0.569, p=0.017). In AAC score ≥7 group, MGP 
levels were positively correlated with AAC score (r=0.608, 
LATAR BELAKANG: Kalsifikasi vaskular merupakan faktor risiko penyakit kardiovaskular pada Penyakit Ginjal Kronik (PGK). Patobiologi 
kalsifikasi vaskular pada PGK sangat kompleks dan 
melibatkan faktor seperti inflamasi, stres oksidatif dan 
keseimbangan regulator kalsifikasi. Penelitian ini bertujuan 
untuk melihat interaksi antara 8-isoprostane dengan 
regulator kalsifikasi yaitu matrix gla protein (MGP) dan 
bone morphogenetic protein (BMP)-2 terhadap kalsifikasi 
vaskular pada PGK.
METODE: Penelitian potong lintang ini dilakukan pada 
63 subyek yang sedang menjalani perawatan hemodialisis 
selama lebih dari 3 bulan. Abdominal aortic calcification 
(AAC) diukur dengan X-ray abdominalis lateral yang 
ditujukan untuk melihat kalsifikasi pada aorta abdominalis, 
yang berhubungan dengan derajat deposit kalsifikasi 
pada segmen vertebra lumbalis (L)1-L4. Kadar serum 
8-isoprostane, MGP dan BMP-2 diukur dengan metoda 
enzyme-linked immunosorbent assay.
HASIL: Penelitian ini menunjukkan kadar 8-isoprostane 
berkorelasi dengan kadar BMP-2 (r=0,266, p=0,018) dan 
MGP (r=0,410, p=<0,001). Rasio kadar MGP/BMP-2 
berkorelasi dengan skor AAC (r=0,279, p=0,013). Subyek 
penelitian dibagi dalam 3 kelompok berdasarkan skor 
AAC, yaitu: 0, 1-6 dan ≥7. Rerata kadar MGP paling 
tinggi terdapat pada kelompok skor AAC 1-6, sedangkan 
rerata kadar 8-isoprostane paling tinggi terdapat pada 
kelompok skor AAC ≥7. Pada kelompok skor AAC 
0, kadar 8-isoprostane berkorelasi dengan kadar MGP 
(r=0,499, p=0,001) dan rasio kadar MGP/BMP-2 (r=0,291, 
p=0,034). Pada kelompok skor AAC 1-6, 8-isoprostane 
berkorelasi dengan kadar BMP-2 (r=0,661, p=0,005) dan 
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p=0.041). With multivariate logistic regression analyses, 
we identified that increased MGP/BMP-2 levels ratio 
(OR: 12.436; 95%CI: 1.595-96.971) was an independent 
predictor in aortic calcification event.
CONCLUSION: We concluded that regulators of 
calcification including calcification inhibitor and promoter 
related to oxidative stress, were associated with vascular 
calcification in CKD. MGP levels were increased in the 
early of calcification and MGP/BMP-2 levels ratio was a 
strong predictor for vascular calcification in CKD.
KEYWORDS: vascular calcification, CKD, oxidative 
stress, 8-isoprostane, MGP, BMP-2
Indones Biomed J. 2013; 5(2): 129-36
Chronic kidney disease (CKD) is globally emerging as 
an important risk factor for morbidity and mortality. 
Some manifestations of CKD range from proteinuria with 
normal renal clearance/function to advanced renal failure 
requiring renal replacement therapy in the form of dialysis 
or transplantation, commonly called end-stage renal disease 
(ESRD).(1)
 In Indonesia, numbers of CKD patients are rising 
rapidly. The prevalence of ESRD patients who underwent 
hemodialysis in 2002 was 1,425 and rised to 3,079 in 2006. 
The prevalence rates per million populations were 10.2 in 
2002 and 23.4 in 2006.(2)
 The majority of subjects with CKD are more likely to 
die of cardiovascular disease (CVD) rather than progress to 
ESRD requiring renal replacement therapy. Cardiovascular 
mortality is the leading cause of death in patients treated 
by dialysis, with mortality 10 to 30 times higher than in 
the general population despite stratification for gender, 
race, and presence of diabetes. Patients with CKD have a 
disproportionate burden of vascular calcification.(1)
 Initially it was believed that high phosphate 
concentrations in CKD caused  vascular calcification simply 
by exceeding the calcium-phosphate solubility products 
that lead to precipitation, but some later studies have shown 
that oxidative stress, high phosphate levels, uremic, bone 
morphogenetic protein (BMP)-2 and high activity level of the 
phosphate transporter pituitary transcription factor (Pit)-1 
induce vascular smooth muscle cell (VSMC)  to differentiate 
from a contractile into an osteoblastic phenotype that behave 
like osteoblast. Once the osteogenic phenotype is induced, 
VSMC gains a distinctive molecular fingerprint, marked by 
the transcription factor core binding factor 1 (Cbfa1) that 
can express alkaline phosphatase (ALP) which synthesize 
hydroxyapatite crystals. Calcification may occur at several 
sites in the cardiovascular system, including the intima and 
media of vessels and cardiac valves. Alternatively, the loss 
of key mineralization inhibitor such as matrix gla protein 
(MGP) also contributes to vascular calcification.(3)
 Oxidative stress may be a significant contributor to 
the accelerated pathology associated with ESRD. Diverse 
mechanisms might account for increased oxidative stress, 
including antioxidant deficiency, neutrophil activation 
during dialysis, and chronic inflammation. Oxidative stress 
reflects an imbalance between the systemic manifestation 
of reactive oxygen species (ROS) and a biological system's 
ability to readily detoxify the reactive intermediates such 
species include free radicals and hydrogen peroxides (H
2
O
2
) 
or to repair the resulting damage. Increased H
2
O
2 
production 
due to activation of the nicotinamide adenine dinucleotide 
phosphate (NADPH) oxidase by inflammatory cytokines 
may activate and translocate nuclear factor kappa-light-chain 
enhancer of activated B cells (NF-kB) in the endothelial 
cells. Binding of NF-kB to its target sequences promotes the 
expression of BMP-2.(4) 8-isoprostanes plasma has been 
established as an indicator of in vivo oxidative stress(5) and 
has been investigated in the pathogenesis of CKD. Research 
on isoprostanes disclosed much information  on  increased 
oxidative stress  and  related  loss  of  kidney  function, in 
early progression of CKD.(6)
MGP (r=0,569, p=0,017). Pada kelompok skor AAC ≥7, 
kadar MGP berkorelasi positif dengan skor AAC (r=0,608, 
p=0,041). Dengan analisis regresi logistik multivariat, kami 
menemukan bahwa  peningkatan rasio kadar MGP/BMP-2 
(OR: 12.436; 95%CI: 1,595-96,971) merupakan prediktor 
independen pada kejadian kalsifikasi aorta.
KESIMPULAN: Kami menyimpukan bahwa regulator 
kalsifikasi termasuk inhibitor dan promotor kalsifikasi yang 
terkait dengan stres oksidatif, berhubungan dengan kejadian 
kalsifikasi vaskular pada PGK. Kadar MGP meningkat di 
awal kalsifikasi dan rasio kadar MGP/BMP-2 merupakan 
prediktor kuat kalsifikasi vaskular pada PGK.
KATA KUNCI: kalsifikasi vaskular, PGK, stres oksidatif, 
8-isoprostane, MGP, BMP-2
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Methods BMPs are the most potent regulators of osteoblast differentiation among the local factors. They belong to the 
transforming growth factor (TGF)-b superfamily. Cbfa1, a 
member of the runt domain gene family, plays a major role in 
the processes of determination of osteoblast cell lineage and 
maturation of osteoblasts. Cbfa1 is an essential transcription 
factor for osteoblast differentiation and bone formation. 
Binding of BMP to its receptor is an important local factor 
that up-regulates Cbfa1 expression in cells. BMP-2 had 
profound effects on proliferation, expression of most of the 
BMPs and the mineralization of human osteoblastic cells.
(7)
 In atherosclerosis, intimal macrophages and VSMCs 
express multiple proteins associated with calcification 
including the vitamin K-dependent protein, MGP.(8) MGP 
has been identified as a calcification inhibitor in cartilage 
and vasculature. MGP is able to bind BMP-2 and promote 
an association between BMP-2 and matrix components. 
Interaction between MGP and BMP-2 interferes binding 
of BMP-2 to its receptor and activation of Smad1, part of 
the BMP signaling system. In vascular calcification, there 
are contradictory findings regarding the effect of MGP that 
might depend on its level ratio to BMP-2. On one hand, MGP 
knockout mice develop profound vascular calcification, 
whereas on the other hand calcifying atherosclerotic lesions 
show an increased expression of MGP.(9) Therefore, this 
study was carried out to investigate the interaction between 
8-isoprostane with calcification regulators such as MGP 
and BMP-2 and the interaction between 8-isoprostane and 
calcification regulators in vascular calcification in CKD.
Study design and Study Subjects
This study was an observational study with cross-
sectional design. The study subjects were recruited from 
haemodialysis centres at several hospitals in Makassar 
from November 2012 until April 2013.  Eligible 63 subjects 
were enrolled based on inclusion criteria as follows: 
male or female, aged above 20 years old with CKD stage 
5 and duration of haemodialysis more than 3 months. 
Information on medications, causes of disease, duration 
of haemodialysis and medical history of diabetes mellitus, 
hypertension, CVD and others was obtained by interview. 
Subjects with history of post parathyroidectomy, post 
kidney transplantation, malignancy, stroke and autoimmune 
disease were excluded. This study protocol was approved 
by The Health and Research Ethics Committee, Medical 
Faculty of Hasanuddin University, Makassar, Indonesia and 
written informed consent was obtained from each subject.
Blood collection and biochemical analysis
Blood pressure (BP) was measured by using mercury 
sphygmomanometer. Blood samples were collected in the 
morning after overnight fasting and before haemodialysis 
procedure. Venous blood was drawn using a serum 
separator tube (SST) and allowed to clot for two hours at 
room temperature before centrifugation for 20 minutes at 
approximately 1,000g. Serum was immediately stored 
Grading 
0 :  no calcific deposits in front of the vertebra
1 :  small scattered calcific deposits filling less than 1/3 of the longitudinal wall of the aorta
2 :  1/3 - 2/3 of the wall calcified
3 :  2/3 or more of the wall calcified
Composite score (AAC)
Posterior wall
Range 0-3
Anterior wall
Range 0-3
Anterior-Posterior severity
Range 0-6
L1 1 1 0 1
L2 1 2 1 3
L3 1 3 2 5
L4 1 3 3 6
Total 4 9 6 15
Maximum 4 12 12 24
Level Affected segment
Scores for individual segments
Figure 1. Abdominal aorta calcification (AAC) scoring.(10) (Adapted with permission from Nature Publishing Group).
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Table 1 showed the characteristics of the subjects (median 
duration of dialysis 1 (1-9) years; mean age 47.8±10.9 years 
old). Subjects were stratified into 3 groups based on  AAC 
score refer to a previous study(11) as follows: AAC score 0, 
1-6  and  ≥7 groups.
 Kolmogorov-Smirnov distribution test showed MGP 
and ratio MGP/BMP-2 had a normal distribution, while data 
Results
frozen in aliquots at -20oC until assay was done. Blood 
collection for 8-isoprostane assay was done with special 
precaution due to instability of the biomarker. The serum 
was stored frozen with the addition of 0.005% butylated 
hydroxytoluene (BHT) to prevent oxidative formation of 
8-isoprostane and also supplemented with indometacin to 
give a final concentration of at least 10 mM to prevent ex vivo 
formation of eicosanoids. The concentration of 8-isoprostane 
was measured by competitive enzyme immunoassay (EIA) 
method using 8-isoprostane EIA kit (Cat. 516351, Cayman 
Chemical, Ann Arbor, MI). MGP was measured by enzyme-
linked immunosorbent assay (ELISA) method using human 
MGP ELISA kit (Cat. E91477Hu, USCN Life Science, Inc., 
Wuhan, China) and BMP-2 was measured by ELISA method 
using  Quantikine BMP-2 Immunoassay (Cat. DBP200, 
R&D systems, Inc., Minneapolis, MN). All assays were 
carried out at Research & Esoteric Laboratory of Prodia 
Clinical Laboratory, Jakarta, Indonesia. The Abdominal 
Aortic Calcification (AAC) was measured semiquantitively 
using a lateral abdominal X-ray in which both  location and 
severity of the calcific deposits at each lumbar vertebral 
segment (L)1–L4. Lateral radiography was performed in the 
standing position using standard radiographic equipment. A 
minimum of 4 cm anterior to the lumbar spines had to be 
visible: the film distance was 100 cm, other adjustments 
were: 94KPV, 33-200mAs and the estimated dose of 
radiation was approximately 15 mGy. The calcification of 
0 1-6 ≥7
(n=40) (n=14) (n=9) 
     Gender 0.831
        Male 60.3% 57.5% 64.3% 66.7%
        Female 39.7% 42.5% 35.7% 33.3%
     Age (year) 47.8 ± 10.9 43.7 ± 9.6 53.8 ± 8.8 56.9 ± 10.4 0.000**
     Duration of HD 0.250
        <2 years 68.3% 67.5% 57.1% 88.9%
        2-4 years 23.8% 25.0% 28.6% 11.1%
>4 years 7.9% 7.5% 14.3% 0.0%
     BMI (kg/m2) 22.5 ± 3.8 22.2 ± 3.7 23.5 ± 3.6 22.3 ± 4.7 0.378
     Diabetes Mellitus 19.0% 12.5% 28.6% 33.3% 0.215
     SBP (mmHg) 146.2 ± 23.2 152.4 ± 21.3 133.6 ± 24.0 138.3 ± 22.1 0.018*
     DBP (mmHg) 87.3 ± 15.1 91.3 ± 13.5 81.4 ± 17.5 78.3 ± 12.2 0.005**
Variable Total Samples 
(n=63)
AAC Score
p
Table 1. Baseline characteristic of subjects.
Mann Whitney test, HD: haemodialysis, BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure, *p≤0.05, 
**p≤0.01.
the aorta was graded and scores were calculated using two 
methods: (a) the composite score for anterior–posterior 
severity where the scores of individual aortic segments 
both for the anterior and posterior walls were summed 
(maximum score 24), and (b) the affected segments score 
as the total number of aortic segments showing any level of 
calcification is indicated (maximum score 4). The scoring 
system is depicted schematically in Figure 1(10).
Data analysis
Statistical analysis was performed with SPSS for Windows 
version 17.0 (SPSS Inc., Chicago, IL) for descriptive 
analysis, Kolmogorov-Smirnov distribution test, Mann-
Whitney test, Spearman correlation and multivariate logistic 
regression analysis. Hypotheses were tested at a significance 
level of 0.05.
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0 1-6 >7
(n=40) (n=14) (n=9)
     8-isoprostane (pg/ml) 70.7 (17.2-543.4) 58.8 (33.5-229.2) 94.1 (37.2-543.4) 0.180
     BMP-2 (pg/ml) 34.9 (15.9-311.1) 31.8 (19.8-86.5) 27.0 (19.1-72.2) 0.654
     MGP (pg/ml) 95,509.5 ± 57,547.1 112,495.2 ± 46,888.9 98,002.2 ± 34,749.6 0.585
     MGP/BMP-2 2,505.7 ± 1,541.4 3,260.2 ± 1,487.1 3,126.7 ± 1,359.6 0.209
Variable
AAC Score
p_
Table 2. Biochemical Characteristic of the subjects in each group.
Chi-square test, MGP/BMP-2: MGP/BMP-2 levels ratio
Table 3. Correlation of 8-isoprostane, BMP-2, MGP and MGP/BMP-2 levels ratio with AAC score in each group.
r p r p r p r p
     8-isoprostane (pg/ml) 0.150 0.121 - - 0.030 0.460 -0.077 0.422
     BMP-2 (pg/ml) -0.127 0.160 - - -0.238 0.207 -0.110 0.389
     MGP (pg/ml) 0.151 0.118 - - -0.207 0.238 0.608 0.041*
     MGP/BMP-2 ratio 0.279 0.013* - - 0.074 0.401 0.287 0.227
AAC Score
Variable Total Samples 0 1-6  >7(n=63) (n=40) (n=14) (n=9)
_
Spearman correlation test, MGP/BMP-2: MGP/BMP-2 levels ratio
r p r p r p r p
     BMP-2 (pg/ml) 0.266 0.018* 0.146 0.185 0.661 0.005** 0.339 0.186
     MGP (pg/ml) 0.410 0.000** 0.499 0.001** 0.569 0.017* -0.203 0.300
     MGP/BMP-2 0.096 0.227 0.291 0.034* -0.147 0.308 -0.390 0.150
Variable 0 1-6   >7
(n=40) (n=14) (n=9)
_
8-isoprostane (pg/ml)
AAC Score
Total Samples
(n=63) 
Table 4. Correlation of 8-isoprostane with MGP, BMP-2 and MGP/BMP-2 levels ratio in each group.
Spearman correlation test, MGP/BMP-2: MGP/BMP-2 levels ratio, *p≤0.05, **p≤0.01
Table 5. Univariate and multivariate logistic regression analysis
OR 95% CI p OR 95% CI p
     8-isoprostane (pg/ml) 1.476 0.527 - 4.137 0.459 1.683 0.303 - 9.355 0.552
     BMP-2 (pg/ml) 0.696 0.248 - 1.953 0.491 1.148 0.212 - 6.225 0.873
     MGP (pg/ml) 1.589 0.565 - 4.465 0.380 0.649 0.103 - 4.081 0.645
     MGP/BMP-2 3.231 1.111 -9.393 0.031 12.436 1.595 - 96.971 0.016
Variable
Univariate Analysis Multivariate Analysis
Logistic regression analysis, MGP/BMP-2: MGP/BMP-2 levels ratio, OR: odds ratio, CI: confidence interval
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Discussion
Vascular calcification is a form of ectopic mineralization 
which arises from deposition of calcium and phosphate in 
major arteries and cardiac valves. The incidence of vascular 
calcification is positively correlated with high mortality 
and morbidity rate for CVD, this is due to the formation of 
hydroxyapatite crystals in the distinct layers of blood vessels 
that is responsible for increased stiffness and decreased 
compliance of arterial walls. The most severe form of 
calcific vasculopathy is medial calcification that is observed 
in ESRD which occurs in the tunica media, the layer that 
supplies mechanical strength and contractile power. It is a 
necrotizing condition triggered by the exposure to increased 
oxidative stress and a condition with inflammation that are 
characteristic of the uremic milieu and negatively affect 
the endothelial function. In the past vascular calcification 
was thought to be an entirely “passive” process and this 
meant that any therapeutic strategy would not have been 
able to reverse or, at least, slow it down. Recent studies 
have pointed out that ectopic calcification instead is a 
highly regulated cell-mediated process which shares many 
similarities with the physiological mineralization in the 
bone. The key cellular effectors of mineralization within 
the vascular wall are the osteoblast-like cells derived from 
VSMCs differentiation. In transformed  VSMCs,  several 
osteoblast-specific  genes become  activated,  and  the  cells 
acquire  the  ability to synthesize bone-specific extracellular 
matrix, to accumulate bone-specific minerals, and to form 
bone-specific tridimensional structures or hydroxyapatite 
crystals.(12) Several stimuli induce VSMCs to undergo 
osteogenic differentiation, including oxidative stress, BMPs 
or changes in pyrophosphate levels.(3)
 Plasma 8-isoprostanes as an in vivo oxidative stress 
is derived from oxidative modification of arachidonic 
acid. Previous studies showed patients on long-term 
haemodialysis might be under increased oxidative stress 
caused by either haemodialysis or renal failure.(5) The 
previous studies demonstrated oxidative stress enhanced 
differentiation of calcifying vascular cells and inhibited 
differentiation of bone cells.(13) Other studies also showed 
a strong relationship between concentrations of circulating 
F2-isoprostanes and the early development of coronary 
artery disease as measured by coronary artery calcium 
(CAC).(14) In our study, we examined weak positive 
correlation between 8-isoprostane level and AAC score 
(r=0.150, p=0.121), which could be explained that there 
were many other risk factors instead of oxidative stress that 
could also have affected the severity of calcification in CKD, 
including age, duration of haemodialysis, diabetes mellitus 
and hypertension. However, we found a positive correlation 
between 8-isoprostane with BMP-2 (r=0.266, p≤0.05) and 
MGP levels (0.410, p≤0.001) in all total subjects. In the 
subject group with early calcification (AAC score 1-6), but 
not in the group with extended calcification (AAC score ≥7), 
it also showed a positive correlation between 8-isoprostane 
with BMP-2 (r=0.661, p≤0.01) and MGP levels (r=0.569, 
p≤0.05). This latter finding may also explain that the role 
of oxidative stress in calcification occurs via promoting the 
expression of mineralization regulators including MGP and 
BMP-2, and enhancing differentiation of VSMC to become 
an osteoblastic phenotype.
 Artery wall calcification associated with 
atherosclerosis frequently contains fully formed bone tissue 
including marrow. BMP-2 a potent factor for osteoblastic 
of 8-isoprostane, BMP-2 and score AAC had an abnormal 
distribution, thus non parametric tests were used for data 
analysis (data not shown).
 Table 2 shows the biochemical characteristics of 
subjects that were stratified into 3 groups. Although no 
statistically significant differences were noted for all 
variables among groups, we found that concentrations of 
MGP and MGP/BMP-2 levels ratio were higher in  AAC 
score 1-6 group than in AAC score 0 and ≥7 groups.
 Age, duration of haemodialysis and acute inflammation 
status were independent risk factors that could be affected on 
the research variables. However, the Spearman correlation 
test showed that there was no correlation of those risk 
factors with all variables, except correlation between 
acute inflammation status represented by high-sensitivity 
C-reactive protein (hsCRP) and 8-isoprostane levels (data 
not shown).
 Table 3 shows significant correlation between AAC 
score and MGP/BMP-2 levels ratio in the total samples 
(r=0.279, p=0.013), and also with MGP in AAC score ≥7 
group (r=0.608, p=0.041).
 Spearman correlation test (Table 4) showed significant 
correlation between 8-isoprostane and BMP-2 in the total 
samples (r=0.266, p=0.018) and in AAC score 1-6 group 
(r=0.661, p=0.005). There were also significant correlation 
between 8-isoprostane and MGP in the total samples 
(r=0.410, p≤0.001), in 0 (r=0.499, p=0.001) and in AAC 
score 1-6 groups (r=0.569, p=0.017).
 Univariate and multivariate logistic regression 
analyses (Table 5) showed that MGP/BMP-2 levels ratio 
(OR: 12.4; 95% CI: 1.595-96.971, p=0.016) was a strong 
predictor for the occurance of vascular calcification in CKD.
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differentiation was found to be expressed in calcified human 
atherosclerotic plaque.(15) BMP-2 secretion is progressively 
increased in bovine VSMCs during mineralization and 
uremic serum enhances its secretion. It is likely that both 
Cbfa1 and BMP-2 may be more critical in the initiation of 
osteoblast-like cell phenotypic change of uremic-serum-
treated bovine VSMCs, but thereafter, other factors are also 
important in the continuation of the calcification.(16)
 MGP is an extracellular matrix protein with wide tissue 
distribution detectable in the normal blood and in calcified 
atherosclerotic plaques. Its main sources are cartilage and 
the vessel wall where it is synthesized by chondrocytes 
and VSMCs, respectively. Its function is to inhibit medial 
calcification of arteries and thereby to protect the normal 
environment in the vascular wall.(17) The mechanisms 
remain unclear. At least two mechanisms could account 
for those mechanisms, first, MGP binds calcium ions and 
hydroxyapatite via its five g-carboxylated glutamic acid 
(Gla) residues, second, MGP has been shown to modulate 
the biological activity of the TGF-b superfamily members 
such as BMPs.(18)
 in vitro study conducted by Zebboudj, et al., showed 
MGP has been demonstrated to exert dose-dependent 
inhibitory effect on osteoblastic differentiation through 
interference with binding of BMP-2 to its receptor. It 
provided evidence that MGP is a regulatory protein for 
BMP-2. MGP has a dose-dependent effect on BMP-2 
induced osteoblastic differentiation in M2 cells. Relative 
low levels of MGP to BMP-2 (less than 1-fold) result in 
mild enhancement of BMP-2 activity. Intermediate levels 
(~1–15-fold) result in inhibition and high levels (above 15-
fold) result in strong enhancement of BMP-2 activity. When 
the levels of MGP exceeded 12–15-fold relative to BMP-2, 
there would be a trend of increased osteoinduction in ALP 
assay and decreased binding of BMP-2 to whole cells and 
matrix. In large excesses of MGP (20–80-fold) relative to 
BMP-2, there is a strong enhancement of the osteoinductive 
effect of BMP-2 and a corresponding activation of Smad1. 
One possible explanation for this phenomenon may be 
saturation of association sites.(9)
 However, other studies have shown MGP significantly 
increased in patients with severe atherosclerosis. Higher 
MGP could therefore be a positive indicator for the 
prognosis due to its function as an inhibitor of medial 
calcification of arteries and may indicate progressing 
media and intima calcification processes. Moreover, these 
processes were paralleled by increased inflammation, which 
may reflect an initial event very early in the process that 
leads to calcification.(17) A study conducted by Proudfoot, 
et al., also showed VSMCs in calcifying cells expressed 
high levels of MGP mRNA. It is possible MGP becomes 
immobilized in the nodular calcifying cells and is unable 
to clear calcium into the external medium. The increase in 
MGP mRNA in the nodular cells may  be  due  to  the  cells' 
detection  of  an  accumulation  of calcium and a feedback 
mechanism for production of additional  MGP.(19)
 Our study results showed the mean of MGP was 
higher in AAC score 1-6 group than in the other groups, 
although statistically not significant, it might indicate that 
calcification process in the media and intima was accelerated 
due to its function as an inhibitor of medial calcification 
of arteries at the early phase of calcification. There was 
significant correlation between AAC score and MGP/BMP-
2 levels ratio in the total CKD samples (r=0.279, p=0.013) 
and with MGP in AAC score ≥7 group (r=0.608, p=<0.05). 
Univariate and multivariate analyses in our study also 
showed that MGP/BMP-2 levels ratio (OR: 12.4, 95%CI: 
1.595-96.971, p=0.016) was a strong predictor for vascular 
calcification events.
 Overall results of this study suggested that 
8-isoprostane as an oxidative stress may be one of the 
contributors to the accelerated vascular calcification events 
associated with CKD via enhancing osteogenic regulator 
both inhibitor and promoter calcification. The highest mean 
of MGP level at the AAC score 1-6 group may indicate 
as a feedback mechanism of cells to produce additional 
MGP to clean up excessive calcium and also indicate that 
media and intima calcification still progresses in the early 
phase of calcification. Positive correlation between MGP/
BMP-2 levels ratio with severity of calcification suggested 
that increased levels of MGP exceeding relative to BMP-
2 indicate larger excess of MGP relative to BMP-2, the 
stronger enhancement of the osteoinductive effect of BMP-
2 which could also induce differentiation of VSMC to an 
osteoblastic phenotype.
 Vascular calcification in this study was determined as 
AAC measured using a lateral abdominal X-ray as described 
by Honkanen, et al., and Belassi, et al.(10,11) The X-ray 
was less sensitive than Computed Tomography (CT)-based 
technique, hence it is one of the limitations of this study. 
Further studies using more sensitive technique to assess 
vascular calcification and involving more eligible number of 
samples are required to provide more valuable information 
about relationships between oxidative stress and osteogenic 
regulator with vascular calcification in CKD. This approach 
might prove to be a useful tool that would compliment 
strategy in pharmacologic therapy of vascular calcification 
in CKD.
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Conclusion
We concluded that regulators of calcification including 
inhibitor and promoter of calcification related to oxidative 
stress are associated with vascular calcification in CKD. 
We found that MGP level increased in the early phase of 
calcification and MGP/BMP-2 levels ratio was a strong 
predictor for vascular calcification in CKD.
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